Prospective observational study of correlation between hematopoietic cell infusion-related adverse events and post-transplant complications.

Prospective observational study of correlation between hematopoietic cell infusion-related adverse events and post-transplant complications. - Prospective observational study of correlation between hematopoietic cell infusion-related adverse events and post-transplant complications.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044194

Enrollment

600

Registered

2021-06-30

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recipient of hematopoietic stem cell transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All allogenic hematopoietic stem cell infusion performed on 15 years of age or older at participating institution.

Exclusion criteria

Exclusion criteria: (1)Patients whose consent for this study are not available. (2)Patient who disagree to the survey Transplant Registry Unified Management Program. (3)Donor Lymphocyte Infusion (4) Autologous transplantation (5) Other patients who are judged by the physician in charge to be inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
Incidence of complications (PIR, Engraftment failure, TMA, VOD/SOS, GVHD, or Viral Infection) at 100 days after transplantation in association with hematopoietic cell infusion-related adverse events.	—

Secondary

Measure	Time frame
2-year overall survival by incidences of hematopoietic cell infusion-related adverse events	—

Countries

Japan

Contacts

Public ContactKeiji Minakawa

Fukushima Medical University Hospital Department of Blood Transfusion and Transplantation Immunology

inf-hsct@fmu.ac.jp024-547-1536

Outcome results